Rotech to supply CPAP alternative 

ORLANDO, Fla. – Rotech Healthcare has announced a supplier agreement with Signifier Medical Technologies to introduce the eXciteOSA device to payers, health care providers and patients to treat mild to moderate obstructive sleep apnea. 

The eXciteOSA device, approved by the U.S. Food and Drug Administration, uses neuromuscular electrical stimulation to tone tongue muscles to maintain an open airway during sleep, improving sleep quality and overall health. 

“Partnering with Signifier Medical Technologies is an exciting step forward for us,” said Robin Menchen, CEO at Rotech Healthcare. “The eXciteOSA device offers an easy-to-use and effective treatment for OSA, and we are proud to bring this cutting-edge technology to our network of payers and health care providers, ultimately benefiting countless patients.” 

Earlier this year, CMS established a new HCPCS code for the eXciteOSA device and the state Medicaid program in South Carolina has also approved it for coverage. 

Rotech says the eXciteOSA device will be available through its distribution channels, ensuring broad accessibility. 

“Rotech Healthcare’s extensive reach and commitment to patient care make them an ideal partner for us,” said Professor Akhil Tripathi, co-founder and managing director of Signifier Medical Technologies. “Together, we can ensure that patients suffering from OSA have access to innovative and effective treatment options.” 

Related: 

• Earlier this year, Signifier Medical Technologies received a “milestone” order of 10,000 units of its eXciteOSA device, placed by Spectrum Sleep Solutions, in the wake of the device’s approval by the state Medicaid program in South Carolina. 
• In 2022, Signifier Medical Technologies announced that Waha Capital PJSC, Angelus Sano Fund L.P., Segulah Medical Acceleration AB and others collectively invested approximately $49 million in the purchase of existing shares in the company from shareholders unrelated to the board and management.